Therapies / Therapeutics / Biotech / BioTech / Drugs / Physics / Drug / National blog main / San Diego / San Diego blog main / San Diego top stories / AbbVie / American Society of Clinical Oncology / California Institute for Regenerative Medicine / GTx / Imbruvica / IPO / Life Sciences / Michael Choi / Moores Cancer Center / Nasdaq / Oncternal / Private Companies / Public Companies / Reverse Merger / UC San Diego

Oncternal Therapeutics Goes Public After Reverse Merger With GTx

Posted on: Jun 12, 2019   |   Posted by: Biotech Mag

Oncternal Therapeutics Goes Public After Reverse Merger With GTx

Oncternal Therapeutics has joined the growing ranks of San Diego biotechs to go public, but it didn't go through an IPO to get there. The San Diego-based company said Monday...

Continue reading ...



Other Posts from Biotech Mag